Ex parte GROSS - Page 10




          Appeal No. 1996-3326                                                        
          Application No. 08/063,067                                                  


                                      APPENDIX                                        

          Claim 1.     A method of prophylaxis or treatment of a subject              
          for systemic hypotension caused by pathological overproduction              
          of nitric oxide from arginine induced in vascular smooth                    
          muscle cells in said subject by therapy of said subject with a              
          cytokine, said method comprising administering to said subject              
          of a therapeutically effective amount of (a) at least one                   
          guanosine triphosphate pathway tetrahydrobiopterin synthesis                
          antagonist which is not a reduced pterin that is a substrate                
          for the pterin salvage pathway or (b) at least one                          
          dihydrofolate reductase inhibitor or both (a) and (b), thereby              
          to inhibit nitric oxide synthesis in said cells to ameliorate               
          said hypotension.                                                           
          Claim 6.     A method of treatment of a subject for systemic                
          hypotension or expected systemic hypotension caused by                      
          pathological overproduction of nitric oxide from arginine                   
          induced in vascular smooth muscle cells in said subject by                  
          bacterial endotoxins, said method comprising administering to               
          said subject of a therapeutically effective amount of (a) at                
          least one guanosine triphosphate pathway tetrahydrobiopterin                
          synthesis antagonist which is not a reduced pterin that is a                
          substrate for the pterin salvage pathway or (b) at least one                
          dihydrofolate reductase inhibitor or both (a) and (b), thereby              
          to inhibit nitric oxide synthesis in said cells to ameliorate               
          said hypotension.                                                           












                                          10                                          





Page:  Previous  1  2  3  4  5  6  7  8  9  10  11  Next 

Last modified: November 3, 2007